Clinical Trials Browser

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Pathologic Complete Response, Breast Neoplasms, Triple Negative Breast Neoplasms

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

Triple Negative Breast Neoplasms

Breast Neoplasms

Triple Negative Breast Neoplasms

Triple Negative Breast Neoplasms

Breast Neoplasms, Neoplasms

Breast Neoplasms

Breast Neoplasms

Stomach Neoplasms

HER2 Positive Early Breast Cancer

Hormone Receptor Positive HER-2 Negative Breast Cancer

Breast Neoplasms

Breast Neoplasms

Carcinoma, Hepatocellular

Stomach Neoplasms

Lung Neoplasms

Inflammatory Breast Neoplasms

Breast Neoplasms

Carcinoma, Hepatocellular

Breast Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

Breast Neoplasms

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

Primary Breast Cancer

Stomach Neoplasms

Breast Neoplasms

Primary Breast Cancer

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms, Breast Neoplasms, Male

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

Breast Neoplasms

Carcinoma, Hepatocellular

Breast Neoplasms

Breast Neoplasms

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Clinical Trials

Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast Cancer

Neoadjuvant Pyrotinib in HR-positive and HER2-low High-risk Early Breast Cancer

PANSY

NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC

A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA

A Multi-center, Randomized, Open-label, Phase III Study Comparing PD-1 Inhibitor Combined With Antivascular Therapy and Anthracycline/Taxane-based Adjuvant Chemotherapy Versus Anthracycline/Taxane-based Adjuvant Chemotherapy Alone in Patients With Operable Triple-negative Breast Cancer

TCTN

CITRINE

Non-Inferiority Study on MRNA-lncRNA Model in Low-Risk Triple-Negative Breast Cancer Patients

PANTHER

TRAIN-2

TavIx

SVOSA

EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast Cancer

TCb vs EC-T in High Risk ER+/HER2- Breast Cancer

EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer

Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer

TACE With Dicycloplatin(TP21) in Unresectable HCC

The Comparison of XELOX and EOX in the First-line Treatment of Advanced Gastric Cancer

Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer

PEGASE07

GAIN-2

Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus

A Randomized Trial Comparing EC-wPversus EP-wP as Adjuvant Therapy for Operable Breast Cancer Patients Less Than 40 Years Old

Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer

Study Comparing Paclitaxel Plus Carboplatin Versus Anthracyclines Followed by Docetaxel as Adjuvant Chemotherapy for Triple Negative Breast Cancer (PATTERN)

Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy

Adjuvant 6 Cycles of Docetaxel and Cyclophosphamide or 3 Cycles of Cyclophosphamide/Epirubicin/Fluorouracil Followed by 3 Cycles of Docetaxel Versus 4 Cycles of Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Operable Breast Cancer (MASTER)

Low-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer

4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF

planB

Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients

TaiNAC

Dose-adjusted Adjuvant FEC Compared to Standard FEC for Breast Cancer

TACT2

READ

Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast Cancer

Neo-shorter

A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)

NNBC3-Europe

The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

PERS

NATT

TACE Combined With Synchronous Radiofrequency /Microwave Ablation to Treat Large and Huge Hepatocellular Carcinoma

Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma

Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE)

BREAST-10

TEX

MIG5

Epirubicin and Docetaxel Combination (ET) or Epirubicin Followed by Docetaxel (E/T) for Node Negative (N0) High Risk Breast Cancer Patients